secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2025-09-04T23:59:59+00:00
Accession:  0001479681-25-000072
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health appoints Michael L. Reed as Lead Independent Director
------------------------------------------------------------------

- Michael L. Reed appointed Lead Independent Director effective Sept 2, 2025.
- Reed has served on Nutex Health board since April 2022; member of Audit, Compensation, and Nominating/Governance committees.
- Role includes presiding over independent director sessions and serving as liaison between board and management.
- Reed will receive additional compensation per company's director compensation program as disclosed in June 2025 proxy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000147968125000072/0001479681-25-000072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000147968125000072/nutx-20250904.htm
  HTML page:      https://secwatch.observer/filing/0001479681-25-000072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer